A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma-Reference-Cited by-同舟云学术

A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Published:2021-01 Issue:1 Volume:109 Page:134-144
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Mahmood Umair,Bang Andrew,Chen Yu-Hui,Mak Raymond H.,Lorch Jochen H.,Hanna Glenn J.,Nishino Mizuki,Manuszak Claire,Thrash Emily M.,Severgnini Mariano,Sanborn Matthew,Sridharan Vishwajith,Margalit Danielle N.,Tishler Roy B.,Busse Paul M.,Willers Henning,Mamon Harvey J.,Yoo Hyung-Jin,Pai Sara I.,Wirth Lori J.,Haddad Robert I.,Chau Nicole G.,Schoenfeld Jonathan D.

Funder

Merck

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference39 articles.

1. Salivary gland tumors: Molecular characterization and therapeutic advances for metastatic disease;Schvartsman;Head Neck,2019

2. Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck;Sung;Arch Otolaryngol Head Neck Surg,2003

3. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies;Airoldi;Cancer,2001

4. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients;Licitra;Ann Oncology,1996

5. Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma;Tchekmedyian;J Clin Oncol,2019

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma;2024-09-07

2. Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials;European Journal of Cancer;2024-09

3. Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances;MedComm;2024-09

4. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade;British Journal of Cancer;2024-08-03

5. Radiotherapy, immunity, and immune checkpoint inhibitors;The Lancet Oncology;2024-08